Li Y-G, Pastori D, Lip GYH. Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice. Ann Med. 2018. https://doi.org/10.1080/07853890.2018.1460489
When the above article was first published online, an older version of Table 2 was included in the proof, which has now been replaced with the new version. In the revised version of Table 2, a new reference is cited in the footnote as reference number 101, which has also been newly included in the reference list as “Halvorsen S, Atar D, Yang H, et al. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. Eur Heart J. 2014;35:1864–1872”.